William Plovanic
Stock Analyst
(2.99)
# 261
Out of 4,648 analysts
120
Total ratings
39.74%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $15 → $17 | $15.04 | +13.03% | 5 | Oct 30, 2024 | |
| ATRC AtriCure | Maintains: Buy | $49 → $53 | $33.82 | +56.74% | 8 | Oct 30, 2024 | |
| NARI Inari Medical | Maintains: Buy | $71 → $74 | $48.83 | +51.55% | 14 | Oct 29, 2024 | |
| EW Edwards Lifesciences | Maintains: Hold | $66 → $63 | $66.49 | -5.25% | 23 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $98 | $84.00 | +16.67% | 8 | Oct 24, 2024 | |
| ANGO AngioDynamics | Maintains: Buy | $13 → $12 | $6.76 | +77.51% | 5 | Oct 4, 2024 | |
| PODD Insulet | Maintains: Buy | $236 → $269 | $236.87 | +13.57% | 2 | Sep 25, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $122 → $137 | $78.07 | +75.48% | 8 | Sep 25, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $120 → $115 | $107.83 | +6.65% | 2 | Sep 10, 2024 | |
| STIM Neuronetics | Maintains: Buy | $6 → $3 | $1.08 | +179.07% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $14.19 | -15.43% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $32.49 | +75.44% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $89 | $70.09 | +26.98% | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $3.93 | +205.35% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $11 | $5.31 | +107.35% | 9 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $232.24 | +22.29% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $8.41 | +197.27% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $7.17 | +67.36% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $99.36 | -29.55% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $29.06 | +65.18% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $14.90 | +47.70% | 3 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $91 → $86 | $84.02 | +2.36% | 3 | May 18, 2023 |
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $15.04
Upside: +13.03%
AtriCure
Oct 30, 2024
Maintains: Buy
Price Target: $49 → $53
Current: $33.82
Upside: +56.74%
Inari Medical
Oct 29, 2024
Maintains: Buy
Price Target: $71 → $74
Current: $48.83
Upside: +51.55%
Edwards Lifesciences
Oct 25, 2024
Maintains: Hold
Price Target: $66 → $63
Current: $66.49
Upside: -5.25%
Boston Scientific
Oct 24, 2024
Maintains: Buy
Price Target: $98
Current: $84.00
Upside: +16.67%
AngioDynamics
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $6.76
Upside: +77.51%
Insulet
Sep 25, 2024
Maintains: Buy
Price Target: $236 → $269
Current: $236.87
Upside: +13.57%
iRhythm Technologies
Sep 25, 2024
Maintains: Buy
Price Target: $122 → $137
Current: $78.07
Upside: +75.48%
Zimmer Biomet Holdings
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $107.83
Upside: +6.65%
Neuronetics
Aug 13, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.08
Upside: +179.07%
Aug 13, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $14.19
Upside: -15.43%
Aug 8, 2024
Initiates: Buy
Price Target: $57
Current: $32.49
Upside: +75.44%
Jul 26, 2024
Maintains: Buy
Price Target: $145 → $89
Current: $70.09
Upside: +26.98%
Jun 27, 2024
Maintains: Buy
Price Target: $12
Current: $3.93
Upside: +205.35%
May 8, 2024
Maintains: Hold
Price Target: $17 → $11
Current: $5.31
Upside: +107.35%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $232.24
Upside: +22.29%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $8.41
Upside: +197.27%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $7.17
Upside: +67.36%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $99.36
Upside: -29.55%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $29.06
Upside: +65.18%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $14.90
Upside: +47.70%
May 18, 2023
Maintains: Buy
Price Target: $91 → $86
Current: $84.02
Upside: +2.36%